Weight Loss on 1 mg Semaglutide: What the Evidence Shows

Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide therapy begins with low doses for safety and tolerability, typically starting at 0.25 mg before titrating upward. Many patients wonder whether a 1 mg dose—often reached by week three or four of treatment—delivers meaningful weight loss on its own. The answer depends on your individual physiology, genetic predispositions, and commitment to lifestyle change.

What Clinical Studies Show About 1 mg Semaglutide Dosing

Research on semaglutide demonstrates dose-dependent weight loss across the therapeutic range. In early-phase trials, patients receiving doses at or around 1 mg showed weight reductions ranging from 4% to 8% of baseline body weight over 12 weeks, with continued loss extending into longer study periods. These results occur when combined with standard dietary and exercise guidance, establishing 1 mg as a meaningful therapeutic threshold rather than merely a transition dose.

The STEP trials, which evaluated semaglutide for chronic weight management, revealed that lower doses activate GLP-1 receptor pathways sufficient to reduce hunger signals and improve appetite control. At 1 mg, patients typically experience noticeable decreases in portion sizes and reduced cravings for high-calorie foods—mechanisms that drive sustained weight loss over time. Individual response varies significantly, with some patients achieving 10%+ weight loss at this dose while others require higher amounts for optimal results.

How Your Genetics Influence Semaglutide Response at 1 mg

Your genetic makeup determines how efficiently your body responds to GLP-1 therapy. Variations in the GLP1R gene (such as rs6923761) and the GIPR gene (rs1800437) directly affect receptor sensitivity and ligand binding—meaning some individuals experience robust appetite suppression at 1 mg while others show minimal initial response. Additionally, FTO gene variants (rs9939609) influence metabolic efficiency and fat storage patterns, shaping how effectively semaglutide's weight loss benefits translate into lost pounds.

PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 150+ genetic insights to reveal your individual peptide response profile. This test identifies whether your GLP-1 receptor sensitivity predisposes you to strong early results at 1 mg or suggests that you may benefit from faster dose escalation. Understanding these genetic factors allows your care team to personalize your treatment trajectory and set realistic expectations for weight loss timing and magnitude.

Signs That 1 mg Semaglutide Is Working for Your Weight Loss

Effective semaglutide response at 1 mg typically appears within the first two to four weeks and includes reduced hunger between meals, smaller portion sizes without deliberate restriction, and decreased preoccupation with food. Many patients report that foods they previously craved become less appealing, and they naturally eat fewer calories without the constant mental effort dieting usually requires. If you experience these appetite-control benefits, weight loss usually follows—even if the scale moves gradually at first.

However, the absence of hunger signals does not guarantee immediate weight loss, particularly if caloric intake remains elevated or exercise is minimal. Some patients on 1 mg feel satisfied eating smaller portions but still consume more total calories than their body burns. In these cases, continuing the dose while reinforcing dietary consistency and activity levels often produces results within 6 to 12 weeks. If you notice no appetite changes and minimal weight loss after one month at 1 mg, PlexusDx specialists can evaluate whether dose escalation or additional metabolic support aligns with your genetic profile.

Optimizing Your 1 mg Semaglutide Strategy with PlexusDx

PlexusDx Compounded Semaglutide Injection starts at $149 per month with consistent pricing across all dose levels—meaning your medication cost remains stable whether you stay at 1 mg or advance to higher therapeutic doses. This flat-rate model removes financial barriers to personalized dosing adjustments and ensures you can optimize your therapy based on clinical response rather than budget constraints. All medications come from licensed 503A compounding pharmacies, maintaining pharmaceutical quality while offering affordability without insurance requirements.

To maximize 1 mg results, pair your injections with structured nutrition guidance and baseline activity tracking. PlexusDx assessments help identify whether your weight plateau reflects inadequate dosing, metabolic adaptation, or lifestyle factors needing adjustment. If you're a candidate, adding the Precision Peptide Genetic Test ($99 add-on after your first month) provides actionable insights into your GLP-1 and GIP receptor biology, peptide pathway efficiency, and whether alternative compounds like tirzepatide might offer synergistic benefits. HSA/FSA eligibility makes personalized GLP-1 therapy accessible to more patients seeking evidence-based weight loss support.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I lose 10 pounds per month on 1 mg semaglutide?

Initial weight loss varies widely, but 1–2 pounds per week is typical for many patients—equaling 4–8 pounds monthly. Losses exceeding this rate often reflect water weight or unusually high baseline caloric restriction. PlexusDx specialists can assess whether your individual response warrants dose escalation or if lifestyle adjustments will optim...

How long does it take to feel semaglutide's appetite-suppressing effects at 1 mg?

Most patients notice reduced hunger and appetite within 3–7 days of reaching 1 mg dosing, though the effect strengthens over 2–3 weeks as the dose settles. If you feel no appetite change after two weeks at 1 mg, your GLP1R sensitivity may require a higher dose or your body may respond better to tirzepatide, which activates additional peptide pat...

Why is PlexusDx Semaglutide Injection only $149 per month?

PlexusDx partners with licensed 503A compounding pharmacies to eliminate markup layers between manufacturer and patient. Flat monthly pricing means your investment stays the same whether you remain at 1 mg or advance to 2.4 mg—supporting accessible, personalized care without flat per-compound pricing escalation.

Is 1 mg semaglutide safe for long-term weight management?

Yes—1 mg is within therapeutic range and well-tolerated in clinical trials lasting 12+ months. Common mild side effects include nausea and reduced appetite (intended effects), which typically diminish after week two. Serious adverse events are rare at this dose, though pre-existing thyroid conditions and pancreatitis history warrant medical revi...

How does the Precision Peptide Genetic Test predict my 1 mg response?

PlexusDx's genetic analysis examines GLP1R and GIPR variants, FTO metabolic markers, and MC4R satiety pathways to map your peptide sensitivity profile across 14 biological pathways. Results reveal whether 1 mg aligns with your genetic predispositions or whether you're likely a candidate for faster dose titration, helping your care team personali...

Can You Lose Weight on 1 mg of Semaglutide? Exploring the Possibilities